SIG
60
2
SHW
73
2
DE
45
5
LUV
33
-3
USB
47
4
MRK
50
-3
LLY
50
3
STX
59
6
WMB
56
-4
RRC
52
2
LEN
64
3
T
54
-6
VLO
45
3
XEL
62
-3
ROP
65
6
NOV
48
3
EOG
50
3
NTRS
54
7
AMAT
55
6
TDC
49
2
SIG
60
2
SHW
73
2
DE
45
5
LUV
33
-3
USB
47
4
MRK
50
-3
LLY
50
3
STX
59
6
WMB
56
-4
RRC
52
2
LEN
64
3
T
54
-6
VLO
45
3
XEL
62
-3
ROP
65
6
NOV
48
3
EOG
50
3
NTRS
54
7
AMAT
55
6
TDC
49
2
Financhill
Back

Summit Materials 10K Form

Buy
62

SUM
Summit Materials

Last Price:
40.30
Seasonality Move:
8.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SUM News And Ratings

See the #1 stock for the next 7 days that we like better than SUM

SUM Financial Statistics

Sales & Book Value

Annual Sales: $2.62B
Cash Flow: $34.21M
Price / Cash Flow: 45.17
Annual Sales: $24.68
Price / Book: 1.63

Profitability

EPS (TTM): 2.14000
Net Income (TTM): $272.23M
Gross Margin: $757.06M
Return on Equity: 8.93%
Return on Assets: 4.48%

Summit Materials Earnings Forecast

Key Summit Materials Financial Ratios

  • The Gross Profit Margin over the past 13 years for SUM is 28.90%.
  • The Selling, General & Administrative Expenses for SUM have been equal to 8.03% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 39.93% of Operating Income.
  • The Net Earning history of SUM is 10.91% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 9 years.

Summit Materials Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Construction Materials
Sector: Materials
Current Symbol: SUM
CUSIP: 86614U
Website: summit-materials.com

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 2.62
Quick Ratio: 1.96

Price-to-Earnings

Trailing P/E Ratio: 16.85
Forward P/E Ratio: 18.03

SUM Technical Analysis vs Fundamental Analysis

Buy
62
Summit Materials (SUM) is a Buy

Is Summit Materials a Buy or a Sell?

  • Summit Materials stock is rated a Buy
    The current Summit Materials [SUM] share price is $40.28. The Score for SUM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.